NELAJ, E.; KECAJ, I.; FERACAKU, J.; XHIXHABESI, K.; TASE, M. Benefits of SGLT2 inhibitors on renal and cardiovascular protection, in diabetic patients. South Eastern European Journal of Public Health, [S. l.], p. 200–206, 2024. DOI: 10.70135/seejph.vi.689. Disponível em: https://www.seejph.com/index.php/seejph/article/view/689. Acesso em: 20 sep. 2025.